Marfloxin 80 mg Tablets for Dogs
Country: Austria
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
10-01-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
marbofloxacin 80 mg
Available from:
Krka d.d.
ATC code:
QJ01MA93
Pharmaceutical form:
Tablet
Therapeutic group:
marbofloxacin
Therapeutic area:
Dogs
Authorization date:
2012-11-21
Summary of Product characteristics
Issued: April 2013
AN: 01881/2011
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Marfloxin 80 mg tablets for dogs
Quiflox 80 mg tablets for dogs
Quiflox vet 80 mg tablets for dogs
Marbiflox 80 mg tablets for dogs
Marfloxin 80 mg tablets for dogs (Austria, Belgium, Bulgaria, Estonia, Germany,
Greece, Italy, Ireland, Netherlands, Poland, Portugal, Romania, Slovenia, Spain,
United Kingdom)
Quiflox 80 mg tablets for dogs (Czech Republic, Hungary, Latvia, Lithuania, Slovak
Republic)
Quiflox vet 80 mg tablets for dogs (Sweden, Finland, Norway)
Marbiflox 80 mg tablets for dogs (Denmark, France)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Marbofloxacin…….80 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Light brownish yellow, capsule shaped, biconvex, marble tablets with possible dark
and white spots and scored on the both sides.
The tablets can be divided into halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by strains of microorganisms susceptible to
marbofloxacin in dogs:
skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis,
furunculosis, cellulitis);
urinary tract infections (UTI) associated or not with prostatitis or epididymitis;
respiratory tract infections.
Issued: April 2013
AN: 01881/2011
Page 2 of 6
4.3
CONTRAINDICATIONS
Do not use in dogs aged less than 12 mo
Read the complete document
